Malawi vs Senegal: Antiretroviral therapy coverage for PMTCT
Malawi
96.0%
in 2024
Senegal
94.0%
in 2024
Malawi rank
15th
Senegal rank
18th
Antiretroviral therapy coverage for PMTCT over time
- Malawi
- Senegal
How they compare
Malawi currently reports 96.0% against 94.0% in Senegal, a difference of 2.0%.
The two have swapped places 9 times across 25 shared years of data; in 2000 it was Senegal ahead.
Malawi ranks 15th and Senegal ranks 18th of 84 countries.
Across the 3 decades both report, Malawi averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Malawi | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.1% | 8.8% | 6.3% | Malawi |
| 2010s | 69.5% | 67.4% | 2.1% | Malawi |
| 2020s | 93.6% | 96.6% | 3.0% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Malawi or Senegal?
- Malawi, at 96.0% against 94.0% in Senegal as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Malawi and Senegal?
- 2.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Malawi and Senegal rank globally for antiretroviral therapy coverage for pmtct?
- Malawi ranks 15th and Senegal ranks 18th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).